These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Calcium antagonists: mechanisms of action and relevance to therapeutics. Vaidya AB; Bhatt AD J Assoc Physicians India; 1984 Sep; 32(9):815-8. PubMed ID: 6511773 [No Abstract] [Full Text] [Related]
6. Application of calcium channel blockers in the treatment of cardiovascular diseases. Herman ZS Pol J Pharmacol; 1999; 51(2):201-6. PubMed ID: 10425650 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacological properties and use of calcium channel blockers]. Kostowski W; Obersztyn M Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1701-5. PubMed ID: 6395120 [No Abstract] [Full Text] [Related]
17. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies. Opie LH; Yusuf S; Kübler W Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332 [TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836 [TBL] [Abstract][Full Text] [Related]
20. [Calcium blockers: ventricular arrhythmias are significantly reduced. Prof. F. Messerli, New Orleans, on the value of calcium antagonists in the treatment of hypertension. Interview by Stefanie Mühlbauer]. Messerli F Fortschr Med; 1990 Jun; 108(19):63-4. PubMed ID: 2379905 [No Abstract] [Full Text] [Related] [Next] [New Search]